DUBLIN, Nov. 19, 2020 /PRNewswire/ -- The "Biomedical and ICT Convergence Market by Technology, Solution and Region 2020 - 2025" report has been added to ResearchAndMarkets.com's offering.
This report evaluates the market for convergence between the Information and Communications Technology (ICT) industry and biomedical science and technologies. The report evaluates the latter and analyzes the former in terms of ICT innovation such as connected medical devices. In addition to forecasts for IoT connected healthcare devices, the report also assesses the outlook from 2020 to 2025 for various biomedical products, services, and solutions poised to benefit from various IT and telecom technologies.
The field of biomedicine is concerned with the application of various natural science disciplines for the development of knowledge, interventions, and/or technologies for use in healthcare. The Information and Communications Technology sector focuses on telecommunications, computing, and the integration of both. Related to ICT is the term TMT, which more broadly refers to Technology, Media, and Telecom. Both are related to the use of various digital technologies for communications, applications, commerce, and content. The convergence of biomedical and ICT represents a high opportunity area for both healthcare and ICT industries.
In addition to seeking cures to disease and ailment prevention, the convergence of biomedical and ICT technologies and solutions will lead to improved treatment efficacy as well as overall improvements in healthcare service delivery efficiency and effectiveness. With healthcare costs growing much faster than the general inflation rate, it is of the utmost importance to simultaneously seek improved treatment while continuously driving down business costs. These costs include ongoing operational expenditures as well as expensive R&D such as drug discovery and other pharmaceutical-related areas such as vaccine development that takes into account precision medicine practices.
Various ICT tools may be employed such as IoT enabled monitoring to determine the effectiveness of medical procedures, which can be especially important when administering new and unproven healthcare modalities. One specific example is the administration of vaccines, which is believed to potentially cause harm to a subset of the population based on epigenetics, which is the study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself. This is believed to be an area in which a healthcare modality is designed with one intent (to inoculate one to prevent the onset of disease), but may actually trigger unintended consequences such as causing harm based on an individual's unique gene expression.
One of the fastest-growing areas for ICT in healthcare is the use of wireless access by IP-enabled, handheld digital devices. Wearables and implantable technology hold the promise of a level of monitoring and healthcare administration that is unprecedented in the history of health science. Ranging from treatment administration to clinical decision support, connected devices are a rapidly evolving tool for the advancement of healthcare practices.
These same tools may be used for both reactive and proactive medical modalities such as insulin modification and vaccine optimization respectively. The convergence of ICT and biomedicine is therefore anticipated to lead to both improved economics as well as improve overall public health.
Select Report Findings:
- The biomedical ICT market is expected to reach $57 billion USD by 2025
- North America will lead the biomedical ICT market during the forecasted period
- The hardware technology will represent over 53% of the biomedical ICT market by 2025
- Diagnostic and research will be the prime application area within the biomedical ICT market
- Biomedical and ICT convergence is the foundation for the preponderance of biomedical technology
Key Topics Covered:
1.0 Executive Summary
3.0 Biomedical and ICT Technologies and Solutions
3.1 Technology Analysis
3.2 Biomedical and ICT Application Analysis
3.3 Cloning and Somatic Cell Nuclear Transfer
3.4 Industry Specific Uses
3.5 Cloud Deployment and IT Infrastructure Management
4.0 Company Analysis
5.0 Biomedical ICT Market Analysis and Forecast 2020 - 2025
5.1 Global Biomedical ICT Market 2020 - 2025
5.2 Regional Biomedical ICT Market 2020 - 2025
6.0 Conclusions and Recommendations
6.1 Advertisers and Media Companies
6.2 Artificial Intelligence Providers
6.3 Biomedical Device and Equipment Providers
6.4 Broadband Infrastructure Providers
6.5 Communication Service Providers
6.6 Computing Companies
6.7 Data Analytics Providers
6.8 Contract Research Organizations
6.9 Networking Equipment Providers
6.10 Networking Security Providers
6.11 Semiconductor Companies
6.12 IoT Suppliers and Service Providers
6.13 Software Providers
6.14 Pharmaceuticals and Hospitals
6.15 Enterprise and Government
7.0 Appendix: Connected Medical Device Market Analysis and Forecasts
- Amgen Inc.
- Analog Devices
- Bio-Rad Laboratories
- Carpenter Technology
- Celgene Corporation
- Dentsply Sirona
- First Sensor
- GE Healthcare
- Gilead Sciences
- Haier Biomedical
- Helmer Scientific
- Hoffman-La Roche Ltd.
- Johnson & Johnson
- Lonza Group
- Merck & Co
- Nonin Medical
- Novartis AG
- Novo Nordisk
- NXP Semiconductor
- Pfizer Inc.
- Sanofi Aventis
- Smiths Medical
- TE Connectivity
- Texas Instruments
- Thermo Fisher
- Wright Medical Group
- Zimmer Biomet
For more information about this report visit https://www.researchandmarkets.com/r/2ztaps
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.